VAERS reports by lot

Moderna COVID-19 lot 033K212A: VAERS reports

94 VAERS reports list lot 033K212A as a Moderna COVID-19 vaccine, received between 2022-02-18 and 2024-08-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
94
Reports
23%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5620%
Gastrointestinal4115%
Cardiac / Cardiovascular3914%
Neurological3713%
Respiratory3412%
Injection-site / Local reaction186%
Allergic / Anaphylactic145%
Dermatological (non-injection-site)145%
Musculoskeletal135%
Thrombotic / Hematological73%
Psychiatric / Neuropsychiatric41%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington19
Arkansas10
Michigan9
New York5
Texas5
Wisconsin5
California5
Florida5
Oregon3
Illinois3
Virginia2
New Jersey2

Reports by month received

2022-021
2022-037
2022-0417
2022-0512
2022-0621
2022-0711
2022-088
2022-091
2022-103
2022-112
2022-123
2023-032
2023-061
2023-071
2023-091
2023-111
2023-121
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.